Unlock stock picks and a broker-level newsfeed that powers Wall Street.
6.80
-0.14
(-2.02%)
At close: April 4 at 5:29:50 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-181,240
-164,946
-249,583
-299,919
-265,171
Investing Cash Flow
163,797
149,038
-144,455
74,000
-7,000
Financing Cash Flow
5
834,063
470,855
187,040
318,183
End Cash Position
333,647
1,156,001
333,620
256,803
294,199
Capital Expenditure
--
--
--
-3,000
--
Issuance of Capital Stock
5
882,143
500,406
200,000
336,000
Free Cash Flow
-181,240
-164,946
-249,583
-302,919
-265,171
12/31/2021 - 12/10/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XSPRAY.ST Xspray Pharma AB (publ)
26.05
-9.86%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1800
-4.66%
IMMU.ST Mendus AB (publ)
5.70
+2.46%
ATORX.ST Alligator Bioscience AB (publ)
0.0055
-9.84%
EGTX.ST Egetis Therapeutics AB (publ)
4.0250
-6.50%
KAN.ST Kancera AB (publ)
1.1020
-1.61%
CHOSA.ST CHOSA Oncology AB
0.6680
-4.57%
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
SIMRIS-B.ST Simris Group AB (PUBL)
0.1105
-1.34%
CANTA.ST Cantargia AB (publ)
1.2950
-2.04%